Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Pharma Deals, Investments and M&As in September 2017
In our continuous endeavor to share business intelligence that can help grow your pharmaceutical bus
FDA reorganizes inspection staff; Thermo Fisher buys Patheon for $ 5.2 billion
This week in Phispers, read about the extortion cyberattack and how it impacted hospitals in the UK.
Price gouging by Aspen in Italy; explosion at BASF; India acts on illegal Metformin exports
This week, Phispers gets you news on illegal exports of Metformin in India, Hillary Clinton’s
Generic challenges, the next first-to-files, GDUFA dues (FY 2016) and more
PharmaCompass has assessed the second quarter US Drug Master
File (DMFs) filings. In our view, with
